Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Jan Tavernier"'
Autor:
Bart Vandekerckhove, Anje Cauwels, Gilles Uzé, An Goethals, Stijn De Munter, Nele Vanderroost, Alexander Van Parys, Frank Peelman, Jan Tavernier, Jennyfer Bultinck, Peter Brouckaert, Annick Verhee, Jeroen Hostens, Leander Huyghe, Sandra Van Lint, Niko Kley, Lennart Zabeau
Publikováno v:
EMBO Molecular Medicine, Vol 12, Iss 2, Pp n/a-n/a (2020)
EMBO Molecular Medicine
EMBO Molecular Medicine, Wiley Open Access, 2019, ⟨10.15252/emmm.201911223⟩
EMBO MOLECULAR MEDICINE
EMBO Molecular Medicine
EMBO Molecular Medicine, Wiley Open Access, 2019, ⟨10.15252/emmm.201911223⟩
EMBO MOLECULAR MEDICINE
Systemic toxicities have severely limited the clinical application of tumor necrosis factor (TNF) as an anticancer agent. Activity‐on‐Target cytokines (AcTakines) are a novel class of immunocytokines with improved therapeutic index. A TNF‐based
Autor:
Stefaan De Koker, Yann Bordat, Thomas Wueest, Sandra Van Lint, Dominiek Catteeuw, Gilles Uzé, José Van der Heyden, Annick Verhee, Alexander Van Parys, Anje Cauwels, Geneviève Garcin, Niko Kley, Jan Tavernier, Franciane Paul, Bart Vandekerckhove, Elke Rogge, Sarah Gerlo
Publikováno v:
Cancer Research
Cancer Research, American Association for Cancer Research, 2018, 78 (2), pp.463-474. ⟨10.1158/0008-5472.CAN-17-1980⟩
Cancer Research, American Association for Cancer Research, 2018, 78 (2), pp.463-474. ⟨10.1158/0008-5472.CAN-17-1980⟩
An ideal generic cancer immunotherapy should mobilize the immune system to destroy tumor cells without harming healthy cells and remain active in case of recurrence. Furthermore, it should preferably not rely on tumor-specific surface markers, as the
Autor:
Nadia Bougarne, Viacheslav Mylka, Dariusz Ratman, Ilse M. Beck, Jonathan Thommis, Lode De Cauwer, Jan Tavernier, Bart Staels, Claude Libert, Karolien De Bosscher
Publikováno v:
Frontiers in Immunology
FRONTIERS IN IMMUNOLOGY
Frontiers in Immunology, Vol 10 (2019)
FRONTIERS IN IMMUNOLOGY
Frontiers in Immunology, Vol 10 (2019)
Glucocorticoids (GCs) act via the glucocorticoid receptor (NR3C1, GR alpha) to combat overshooting responses to infectious stimuli, including lipopolysaccharide (LPS). As such, GCs inhibit the activity of downstream effector cytokines, such as tumor
Autor:
Jan Tavernier
Publikováno v:
Cancer Immunology Research. 7:A158-A158
An ideal generic cancer immunotherapy should mobilize the immune system to destroy tumor cells without harming healthy cells and remain active in case of recurrence. Furthermore, it should preferably not rely on tumor-specific surface markers, as the
Autor:
Margarida Maia, Michaël Moons, Astrid De Vriese, Rik Lories, Kristel Van Landuyt, Jan Tavernier, Edward M. Conway, Tom Janssens
Publikováno v:
Arthritis & Rheumatism. 62:3595-3606
Objective CD248 is a transmembrane glycoprotein expressed on the surface of activated perivascular and fibroblast-like cells. This study was undertaken to explore the function of CD248 and its cytoplasmic domain in arthritis. Methods Synovial tissue
Autor:
Nikolai Kley, Sandra Van Lint, Geneviève Garcin, Anje Cauwels, Gilles Uzé, Jan Tavernier, Alexander Van Parys, Franciane Paul
Publikováno v:
Cancer Research. 78:629-629
An ideal generic cancer immunotherapy should mobilize the immune system to destroy tumor cells without harming healthy cells and remain active in case of recurrence. Furthermore, it should preferably not rely on tumor-specific surface markers, as the
Autor:
D. De Valck, Els Decoster, J. Grooten, Rudi Beyaert, Bart Everaerdt, Claude Libert, Walter Fiers, Klaus Schulze-Osthoff, F. Van Roy, Jan Tavernier, N. Takahashi, X. Van Ostade, A. Lenaerts, Bart Vanhaesebroeck, Peter Brouckaert, S. Van Bladel, C. Van Dorpe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e75589bfefa8395f8f4aa75d247e4569
https://doi.org/10.1159/000420771
https://doi.org/10.1159/000420771
Autor:
Rudi Beyaert, Walter Fiers, Bart Vanhaesebroeck, Peter Brouckaert, N. Takahashi, Philip Noel Suffys, Claude Libert, Bart Everaerdt, Jan Tavernier, S. Van Bladel, F. Van Roy, X. Van Ostade, Guy Haegeman
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b411b94fad36504a82cb6f6ef5c6cbe6
https://doi.org/10.1159/000417343
https://doi.org/10.1159/000417343
Autor:
Hui Xue, Zi-Hui Deng, Jin-Ying Zhang, Cuihong Song, Guang-Tao Yan, Kai Zhang, Lennart Zabeau, Jan Tavernier, Chen Liang, Jie Liao
Publikováno v:
International immunopharmacology. 15(3)
Leptin, a 16-kDa protein that is mainly secreted by adipocytes, plays a protective role in many cell types. It has been shown that leptin acts in the central and peripheral immune system to protect thymocytes. Cytosolic phospholipase A 2 (cPLA 2 ) is